US-UK pharma deal isn’t enough to get AstraZeneca investing in Britain again – POLITICO
“It will probably not be sufficient for many of these fully innovative products,” he said. “We need to…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
GSK’s new CEO eyes more dealmaking, intense pipeline inspection – Endpoints News
GSK’s new CEO eyes more dealmaking, intense pipeline inspection Endpoints NewsGSK (FY Results): another step towards mid-term target Hargreaves LansdownGSK…
China’s new commercial insurance model could broaden access to Alzheimer’s drugs
China’s new commercial insurance formulary looks to expand patient access to Alzheimer’s disease medicines from Eli Lilly and…
UK lowers new medicine rebate scheme to 14.5% for 2026 – Endpoints News
UK lowers new medicine rebate scheme to 14.5% for 2026 Endpoints NewsWhat will be the cost of Keir Starmer’s…
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks – Endpoints News
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks Endpoints NewsU.S.…
Trump admin claims win as UK bows to pressure on NHS drug spending – POLITICO
The new NICE threshold will be £25,000 to £35,000 per quality adjusted life year gained over and above…
Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICO
The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…
Redefining nutraceuticals with new delivery formats and pharma-grade standards
The boundaries between pharmaceuticals and nutraceuticals continue to blur. This year’s CPHI 2025 trade show highlighted innovations that…
US pharma to abandon UK unless NHS pays more, says Trump’s ambassador – POLITICO
The U.K. is locked in drug-pricing negotiations with the Trump administration and pharmaceutical firms about how much the…
High energy prices make the UK ‘vulnerable’ US ambassador warns
Wednesday 05 November 2025 8:35 pm Share Facebook Share on Facebook X Share on Twitter LinkedIn Share on…
Britain’s plan to raise NHS drug prices won’t bring back Lilly’s investment – POLITICO
But for the U.S. pharmaceutical company — which shelved its planned facility meant to support early-stage life sciences…